Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1PFIZER INC. New York City US

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

Looking for Certificates of Suitability (CEPs) for R1-CEP 1997-123 - Rev 01 of Pfizer Inc. New York City Us

Looking for Certificates of Suitability (CEPs) for R1-CEP 1997-123 - Rev 01 of Pfizer Inc. New York City Us 1

20

Pfizer Inc. New York City Us, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their significant offerings is Estradiol hemihydrate, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 1997-123 - Rev 01

This Chemical Type CEP, issued on February 16, 2009, remains in force until September 10, 2020, ensuring its reliability within the pharmaceutical industry.

Substance Number 821 associated with this CEP further emphasizes